Stocks · News reference
U.S. stock futures higher, Nasdaq 100 up 150 pts. National CineMedia shares down 16.4% on weak Q2 results and Captivate Holdings acquisition. Other stocks also falling in pre-market trading.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Entravision Communications Corporation has entered into a membership interest purchase agreement to sell the subsidiary holding WFTT-TV in the Tampa-St. Petersburg market to Sunset Boulevard Broadcasting for $30 million in cash.
Entravision Communications Corporation reported an 88% year-over-year increase in third-quarter revenue to $226.3 million, driven by growth in its advertising technology segment.
Entravision Communications Corporation has announced a dividend of $0.05 per share, with an ex-dividend date of December 17, 2026.
Entravision reported 88% consolidated revenue growth to $226 million in Q3 2026, driven by 132% growth in advertising technology revenue. The company is pivoting away from legacy television assets, agreeing to sell Tampa stations for $30 million, while focusing capital on its digital advertising platform. Management plans a capital allocation review for early 2027 and has reduced debt by $15 million year-to-date.
Entravision reported strong Q3 2026 results with consolidated revenue of $226.3 million (88% growth), driven primarily by its Advertising Technology and Services (ATS) segment which grew 133% to $177.2 million. The company achieved operating income of $28.3 million versus a prior-year loss of $9.1 million. However, the media segment remains challenged, and management is exploring strategic alternatives for its TV business following the decision to end its Univision affiliation after March 2027. The company agreed to sell its Tampa TV stations for $30 million and plans to review capital allocation priorities in early 2027.
AbCellera announced that it will participate in the upcoming UBS Global Biopharma Conference scheduled for November 17, 2026.